Antibiotics | AM1 | C | TE | SXT | CET | CIP | CRO | FEB | CAZ | CTX | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ā | S2 | I | R | S | I | R | S | I | R | S | I | R | S | I | R | S | I | R | S | I | R | S | I | R | S | I | R | S | I | R |
CLSI MIC3 breakpoints Ī¼g/mL | ā¤8 | 16 | ā„32 | ā¤ 8 | 16 | ā„ 32 | ā¤4 | 8 | ā„16 | ā¤2/38 | Ā | ā„4/76 | ā¤8 | 16 | ā„32 | ā¤1 | 2 | ā„4 | ā¤1 | 2 | ā„4 | ā¤8 | 16 | ā„32 | ā¤4 | 8 | ā„16 | ā¤1 | 2 | ā„4 |
EP4 isolates (nā=ā10) (1990ā1994) | 0 | 0 | 10 (100)7 | 0 | 0 | 10 (100) | 0 | 0 | 10 (100) | 6 (60) | 2 (20) | 2 (20) | 0 | 2 (20) | 8 (80) | 10 (100) | 0 | 0 | ND8 | Ā | Ā | ND | Ā | Ā | ND | Ā | Ā | ND | Ā | Ā |
EP isolates (nā=ā17) (2000ā2004) | 1 (6) | 0 | 16 (94) | 16 (94) | 0 | 1 (6) | 2 (12) | 0 | 15 (88) | 2 (12) | 0 | 15 (88) | 1 (6) | 14 (82) | 2 (12) | 17 (100) | 0 | 0 | 17 (100) | 0 | 0 | 17 (100) | 0 | 0 | 17 (100) | 0 | 0 | 17 (100) | 0 | 0 |
NEP5 isolates (nā=ā19) (2001ā2003) | 0 | 0 | 19 (100) | 16 (84) | 0 | 3 (16) | 0 | 0 | 19 (100) | 2 (11) | 0 | 17 (89) | 1 (5) | 12 (63) | 6 (32) | 19 (100) | 0 | 0 | 19 (100) | 0 | 0 | 19 (100) | 0 | 0 | 19 (100) | 0 | 0 | 19 (100) | 0 | 0 |
PP6 isolates (nā=ā23) (2002ā2003) | 1 (4) | Ā | 22 (96) | 4 (17) | Ā | 19 (83) | 2 (9) | Ā | 21 (91) | 1 (4) | Ā | 22 (96) | 6 (26) | 17 (74) | 0 | 10 (100) | 0 | 0 | 23 (100) | 0 | 0 | 23 (100) | 0 | 0 | 23 (100) | 0 | 0 | 23 (100) | 0 | 0 |